Literature DB >> 15771755

Diagnosis and treatment of autoimmune hepatitis at age 65 and older.

C Verslype1, C George, E Buchel, F Nevens, W van Steenbergen, J Fevery.   

Abstract

AIM: To study features in older patients with autoimmune hepatitis, as this was considered mainly a disease of young females.
METHODS: Analysis of 28 patients diagnosed at age > or =65 years compared with 84 younger patients.
RESULTS: The incidence was similar at all age decades. The ratio M:F was 1:3 (> or =65 years) vs. 1:2 (<65 years). Presenting symptoms were not different when compared with younger patients and consisted of general malaise and fatigue (36%), jaundice +/- other symptoms (50%), or ascites (11%). Antinuclear antibodies (ANA) > or = 1/80 were positive in 93%, smooth muscle antibodies (SMA) > 1/40 in 50%, anti-liver kidney microsomes (anti-LKM) proved always negative. Histology showed acute necrotizing hepatitis in 19%, severe interphase hepatitis in 15%, chronic hepatitis with plasmo-lymphocytic infiltrate in 30%, cirrhosis in 29% (with active inflammation in one-third); biopsy was refused in 11%. The elderly responded very well to low doses of methylprednisolone (< or =8 mg) and azathioprine (1 mg/kg). This schedule obviates side-effects such as infections seen with higher dosages.
CONCLUSION: Autoimmune hepatitis has to be also looked for in the elderly with acute and chronic hepatitis. The steroid therapy should be individualized but kept at a low dose.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15771755     DOI: 10.1111/j.1365-2036.2005.02403.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  10 in total

1.  Autoimmune Hepatitis in Hawai'i.

Authors:  Tanner I Kim; Jaclyn E Kagihara; Naoky C S Tsai; Marina M Roytman
Journal:  Hawaii J Med Public Health       Date:  2015-08

Review 2.  Global Disparities and Their Implications in the Occurrence and Outcome of Autoimmune Hepatitis.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2017-07-14       Impact factor: 3.199

Review 3.  Nature and Implications of Oxidative and Nitrosative Stresses in Autoimmune Hepatitis.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2016-07-13       Impact factor: 3.199

4.  Anti-mitochondrial M2 antibody-positive autoimmune hepatitis.

Authors:  Minoru Tomizawa; Fuminobu Shinozaki; Kazunori Fugo; Yasufumi Motoyoshi; Takao Sugiyama; Shigenori Yamamoto; Takashi Kishimoto; Naoki Ishige
Journal:  Exp Ther Med       Date:  2015-08-20       Impact factor: 2.447

Review 5.  Autoimmune Hepatitis in the Elderly: Diagnosis and Pharmacologic Management.

Authors:  Syed Rizvi; Samer Gawrieh
Journal:  Drugs Aging       Date:  2018-07       Impact factor: 3.923

Review 6.  Autoimmune hepatitis--approach to diagnosis.

Authors:  Albert J Czaja
Journal:  MedGenMed       Date:  2006-05-23

Review 7.  Clinical features, differential diagnosis and treatment of autoimmune hepatitis in the elderly.

Authors:  Albert J Czaja
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

Review 8.  Evolving Role of Vitamin D in Immune-Mediated Disease and Its Implications in Autoimmune Hepatitis.

Authors:  Albert J Czaja; Aldo J Montano-Loza
Journal:  Dig Dis Sci       Date:  2018-10-28       Impact factor: 3.199

9.  Clinical, serological, histopathological and treatment profile of autoimmune hepatitis in the elderly.

Authors:  Nikhil Sonthalia; Shubham Jain; Ravi Thanage; Parmeshwar Junare; Sanjay Chandnani; Vinay Pawar; Qais Contractor; Pravin Rathi
Journal:  Clin Exp Hepatol       Date:  2020-02-17

10.  Role of age in presentation, response to therapy and outcome of autoimmune hepatitis.

Authors:  Martine A M C Baven-Pronk; Maaike Biewenga; Joanne J van Silfhout; Aad P van den Berg; Henk R van Buuren; Bart J Verwer; Carin M J van Nieuwkerk; Gerd Bouma; Bart van Hoek
Journal:  Clin Transl Gastroenterol       Date:  2018-07-02       Impact factor: 4.488

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.